We are a company that creates the seeds of innovative new drugs (known as development compounds) through the latest science and an open collaboration network. We then deliver truly valuable medicines to patients by licensing these compounds to pharmaceutical manufacturing companies that then that make pharmaceutical products.

At RaQualia Pharma we specialize in the "discovery" phase of drug research and development, which extends from the search, or exploratory, research stage through the initial clinical test stage.

RaQualia Pharma's R&D portfolio is focused on the following therapeutic areas: